Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

8.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alignment of physical education curricula with physical literacy across Europe: an observational mapping study with country-level predictors.

The Lancet regional health. Europe·2026
Same author

Genomic and taxonomic characterization of strain CCM 2573: Uncovering unique genetic features and description of Macrococcus caseolyticus subsp. lactis subsp. nov.

Folia microbiologica·2026
Same author

Late posttonsillectomy haemorrhage, differences in unilateral versus bilateral tonsillectomy, a retrospective epidemiological multicentric study.

Scientific reports·2025
Same author

Psychrotolerant Erwinia psychrophila sp. nov. and Erwinia magellanica sp. nov. Isolated from Penguin Faeces.

Current microbiology·2025
Same author

Ozonization for MALDI-2 MS imaging of carbon-carbon double bond positional isomers of phosphatidylethanolamines in biological tissues.

Analytica chimica acta·2025
Same author

Epidemiology of late postoperative bleeding in OSA-related tonsil surgery: a multicentric retrospective study.

Journal of applied biomedicine·2025

Related Experiment Video

Updated: Feb 19, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.1K

[Thyroid carcinomas: the present view on diagnostics and therapy].

Petr Vlček, Dana Nováková, Rami Katra

    Vnitrni Lekarstvi
    |November 10, 2017
    PubMed
    Summary

    Differentiated thyroid gland carcinomas (DTCs) are the most common thyroid cancers. This review focuses on current treatment strategies for low-risk DTCs, including radioiodine and targeted therapy.

    Area of Science:

    • Oncology
    • Endocrinology

    Background:

    • Thyroid carcinoma (TC) is the seventh most common tumor globally, with incidence rising, particularly in women.
    • Differentiated thyroid gland carcinomas (DTCs), including follicular, papillary, and Hurthle cell types, constitute 95% of new TC cases.
    • While most DTCs have a good prognosis, aggressive forms like anaplastic thyroid cancer and medullary thyroid carcinoma present significant treatment challenges.

    Purpose of the Study:

    • To review current therapeutic procedures for differentiated thyroid carcinomas (DTCs).
    • To focus on contemporary perspectives regarding the management of low-risk DTCs.
    • To discuss the roles of radioiodine and targeted therapy in DTC treatment.

    Main Methods:

    • Literature review of current therapeutic procedures for differentiated thyroid carcinomas.

    More Related Videos

    Spontaneous Murine Model of Anaplastic Thyroid Cancer
    05:39

    Spontaneous Murine Model of Anaplastic Thyroid Cancer

    Published on: February 3, 2023

    2.3K
    Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
    06:08

    Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

    Published on: June 2, 2023

    2.4K

    Related Experiment Videos

    Last Updated: Feb 19, 2026

    Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
    03:55

    Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

    Published on: June 9, 2023

    1.1K
    Spontaneous Murine Model of Anaplastic Thyroid Cancer
    05:39

    Spontaneous Murine Model of Anaplastic Thyroid Cancer

    Published on: February 3, 2023

    2.3K
    Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
    06:08

    Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

    Published on: June 2, 2023

    2.4K
  • Analysis of contemporary opinions on the treatment of low-risk DTCs.
  • Examination of radioiodine and targeted therapy applications.

    • Main Results:

    • Differentiated thyroid gland carcinomas (DTCs) are the predominant type of thyroid cancer, generally having a favorable prognosis.
    • Treatment for low-risk DTCs is evolving, with ongoing evaluation of established and novel therapeutic modalities.
    • Radioiodine therapy and targeted therapy represent key components in the management of DTCs, particularly for residual disease or advanced cases.

    Conclusions:

    • Current treatment strategies for differentiated thyroid carcinomas emphasize optimizing outcomes for low-risk cases.
    • The management of DTCs involves a multidisciplinary approach, considering factors like risk stratification and therapeutic advancements.
    • Continued research into radioiodine and targeted therapies is crucial for improving the long-term prognosis of differentiated thyroid cancer patients.